Best TrueBeam Doctors Worldwide — TOP 23

Leading researcher in thoracic malignancies – Dr. Raphael pioneers genomic profiling and immunotherapy trials at Sourasky Medical Center.

• Principal investigator for multiple NSCLC immunotherapy trials
• Expert in liquid biopsies and comprehensive tumor profiling
• Molecular Tumor Board moderator for Israeli Lung Cancer Society
• Recipient of ISCORT research grant for oncology studies
• ESMO and IASLC member with international training

Prof. Merimsky heads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, specializing in high-precision radiation therapies like TrueBeam for complex cases.

• Over 41 years of experience of experience in orthopedic oncology
• ESMO faculty member for sarcoma and bone cancer
• Pioneered Israel's first dedicated sarcoma treatment program
• Fellowship-trained at Institut Gustave Roussy in Paris

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).

He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.

Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.

Specializes in treating various cancers including breast, lung, and gastrointestinal cancers at Hisar Hospital Intercontinental.

• Graduated from Hacettepe University – one of Turkey's top medical schools
• Completed fellowship at Hacettepe University Cancer Institute
• Worked at The University of Texas MD Anderson Cancer Center
• Handles complex cases like testicular and ovarian cancers

34 years of experience specializing in radiation oncology – Dr. Esra Kaytan Saglam has authored 114 scientific publications in the field.

• Board Member and Chief Editor at the Turkish Society of Oncology
• Vice President of the Turkish Society of Oncology
• Member of the European Society of Therapeutic Radiology and Oncology
• Trained at Istanbul University's Faculty of Medicine

The doctor is a highly qualified medical oncologist specializing in breast cancer across all clinical stages, including curative and palliative care. With a medical degree from the Pontificia Universidad Católica del Ecuador and a five-year residency at Hospital de la Santa Creu i Sant Pau, the doctor holds a Master's Degree in Medical Oncology from the Spanish Society of Medical Oncology (SEOM).

Currently practicing at the International Breast Cancer Center (IBCC) and IOB Institute of Oncology Barcelona, the doctor has extensive experience in Phase I clinical trials and research. Clinical expertise extends to neuroendocrine tumors, gynecological cancers, and immunotherapy for non-small cell lung cancer. The doctor is an active member of SEOM and ESMO.

Director of Radiotherapy Institute Oncology Division at Sourasky Medical Center (Ichilov).

• Specializes in advanced radiotherapy techniques
• Leads a team focused on precise cancer treatment
• Works with cutting-edge TrueBeam technology

Dr. Rabin specializes in advanced radiotherapy techniques, including TrueBeam, at Sourasky Medical Center. She brings expertise from Anderson Cancer Center and leads innovative research.

• Fellowship-trained at Anderson Cancer Center in Houston
• Coordinator for gynecological oncology treatments
• Research focuses on molecular response to radiation therapy
• Member of ASTRO and ISCORT
• Recipient of 'Best Hospital Employee' award

Dr. Alemdar specializes in Medical Oncology with extensive training at Akdeniz University, a leading institution in Turkey.

• Completed medical oncology specialization at Akdeniz University
• Over 20 years of experience of experience in oncology
• Worked at Akdeniz University Hospital and Antalya Training and Research Hospital
• Experienced in managing complex oncology cases

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Assoc. Prof. Atakan Topcu has published over 50 scientific articles on targeted cancer therapies and geriatric oncology at Medipol Acibadem District Hospital.

• Specializes in lung, breast, and gastrointestinal cancers
• Expert in cancer-related malnutrition and immunotherapy
• Member of ESMO and Turkish Society of Medical Oncology
• Fellowship-trained in medical oncology at Bezmialem Vakıf University

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.